Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

NP said recently that these analyses typically take

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JMDB Member Profile
 
Followed By 3
Posts 184
Boards Moderated 0
Alias Born 06/24/20
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/18/2021 4:22:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 4:17:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/14/2021 5:08:03 PM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 10/14/2021 9:27:51 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/7/2021 6:05:08 AM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 10/7/2021 6:04:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2021 5:17:03 PM
Proxy Statement - Non-management (definitive, Revised) (dfrn14a) Edgar (US Regulatory) - 10/6/2021 6:01:06 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 10/4/2021 9:36:50 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/30/2021 9:31:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 5:16:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/29/2021 6:09:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 6:07:32 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 9/28/2021 5:17:31 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/28/2021 10:02:14 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/24/2021 10:11:03 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/22/2021 4:08:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/22/2021 4:06:17 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/21/2021 9:31:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2021 9:30:30 AM
CLS Holdings, (OTCQB: CLSH) FY 2021 $19 Million - 60% Growth - August Alone $1.8 million InvestorsHub NewsWire - 9/21/2021 7:09:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2021 4:02:29 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 9/20/2021 9:31:05 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/17/2021 5:24:23 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/10/2021 4:05:53 PM
JMDB   Tuesday, 07/21/20 07:23:45 PM
Re: None
Post # of 190220 
NP said recently that these analyses typically take 4-6 weeks ( if my memory serves ) and they are looking to get all the work done in a few days, “so please be patient”.

So might be hard to do but any informed guess with rationale behind it on release of those efficacy data?

Also. Still wondering, haven’t gotten response, on when we might expect interim analysis on the severe trial ongoing..?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences